Connect
← Return to New FAPi tracer for PET-CT scans for difficult-to-image cancers
Discussion
New FAPi tracer for PET-CT scans for difficult-to-image cancers
Breast Cancer | Last Active: Sep 28 10:38pm | Replies (3)Comment receiving replies
Hello @olivia7850 Thank you for sharing this important trial with us. Targeted Pet/ct is a new and upcoming technology in cancer detection.
There is one already approved and in use for prostrate cancer, sadly there is a very long wait, and currently only available at select places. We waited for six months and traveled three hours to get it for my husband. If this were a fast growing breast cancer, there definitely would have been problems from the wait time.
Has anyone else had experience with these targeted tracers for imaging?
Replies to "Hello @olivia7850 Thank you for sharing this important trial with us. Targeted Pet/ct is a new..."
Connect
Interestingly, Dr. Jeremie Calais, in charge of the FAPi tracer trial at UCLA, is also working/worked on the PSMA targeted prostate tracer that you discussed above. It is a shame such an important test is not more readily available.
I read that Dr. Calais at UCLA is working on as aspect of PET scans called 'theranostics'. This approach uses PET scan technology combined with radiation to treat certain advanced cancers such as prostate, neuroendocrine tumors and thyroid tumors. Theranostics is currently available, FDA approved and covered by Medicare. I'm not sure if this is what you are referring to in your message.
Another targeted tracer currently in use is FES for estrogen in breast cancer for ER+ folks.
To my the best of my knowledge, the FAPi clinical trials, covering a variety of cancers, are only at UCLA, UCSF and Mayo.